Literature DB >> 20417417

Rhodococcus equi infection.

Alexandra V Yamshchikov1, Audrey Schuetz, G Marshall Lyon.   

Abstract

Rhodococcus equi is a veterinary pathogen that can cause substantial morbidity in patients that are immunocompromised and are occupationally and recreationally exposed to farming, livestock, and dry soil environments. Although the clinical spectrum of disease associated with R equi is broad, pulmonary involvement is a predominant feature in most cases. We present a case of occupationally acquired R equi pneumonia and mediastinal lymphadenitis in a patient that has had a renal transplant and is in receipt of a stable immunosuppression regimen. We review the pathogenesis and clinical characteristics of infections with Rhodococcus spp, and discuss approaches to treatment of this disease entity in populations of patients who are immunocompromised. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417417     DOI: 10.1016/S1473-3099(10)70068-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  60 in total

1.  Nonhealing wound due to Rhodococcus equi in an apparently immunocompetent patient, revealing CD8+ T-lymphocyte deficiency.

Authors:  Eric Denes; Dominique Peignon-Orsoni; François-Xavier Terrade
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

Review 2.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

3.  The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Authors:  Margot Schlusselhuber; Riccardo Torelli; Cecilia Martini; Matthias Leippe; Vincent Cattoir; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Maurizio Sanguinetti; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

Review 4.  Pseudotumor of the tracheal-laryngeal junction with unusual morphologic features caused by Rhodococcus equi infection.

Authors:  Shreeram Akilesh; Sara Cross; Katherine Kimmelshue; Nigar Kirmani; Louis P Dehner; Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2011-04-26

5.  Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.

Authors:  Londa J Berghaus; Steeve Giguère; Kristen Guldbech; Eleanor Warner; Ukachi Ugorji; Roy D Berghaus
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

6.  Pleural malakoplakia caused by Rhodococcus equi infection in a patient after stem cell transplantation.

Authors:  Carl Ludwig Behnes; Silke Neumann; Stefan Schweyer; Heinz-Joachim Radzun
Journal:  Diagn Pathol       Date:  2012-02-23       Impact factor: 2.644

7.  Streptolysin-O/antibiotics adjunct therapy modulates site-specific expression of extracellular matrix and inflammatory genes in lungs of Rhodococcus equi infected foals.

Authors:  Volkan Gurel; Kristyn Lambert; Allen E Page; Alan T Loynachan; Katherine Huges; John F Timoney; Michael Fettinger; David W Horohov; John McMichael
Journal:  Vet Res Commun       Date:  2013-03-09       Impact factor: 2.459

8.  Identification of clinically relevant Corynebacterium spp., Arcanobacterium haemolyticum, and Rhodococcus equi by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Jordi Vila; Pedro Juiz; Carlos Salas; Manel Almela; Celia García de la Fuente; Yuliya Zboromyrska; Jesús Navas; Jordi Bosch; Jesús Agüero; Jorge Puig de la Bellacasa; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

9.  Appearance of multidrug-resistant virulent Rhodococcus equi clinical isolates obtained in China.

Authors:  Huimin Liu; Yutian Wang; Jing Yan; Chengmin Wang; Hongxuan He
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

10.  Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.

Authors:  Alexandra J Burton; Steeve Giguère; Londa J Berghaus; Mary K Hondalus
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.